Dafna Capital Management LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $331 Million distributed in 83 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr Ser Tr Spdr S&P Biotech E with a value of $32.8M, Stereotaxis, Inc. with a value of $24.1M, Revolution Medicines, Inc. with a value of $23.2M, Merus N.V. with a value of $19.4M, and Atri Cure, Inc. with a value of $19.1M.

Examining the 13F form we can see an decrease of $36.6M in the current position value, from $368M to 331M.

Dafna Capital Management LLC is based out at Los Angeles, CA

Below you can find more details about Dafna Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $331 Million
Healthcare: $285 Million
ETFs: $45.9 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 83
  • Current Value $331 Million
  • Prior Value $368 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 8 stocks
  • Additional Purchases 24 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 15 stocks
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.